Recurrences Unknown Status Phase 2 Trials for Rivoceranib (DB14765)

Back to Recurrences

Also known as: Recurrence

IndicationStatusPhase
DBCOND0050633 (Recurrences)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03913182Apatinib in the Treatment of Recurrence or Metastasis of Esophageal CancerTreatment